COMMUNIQUÉS West-GlobeNewswire

RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
23/06/2026
MIAMI, June 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, [...]
SK pharmteco lance SKyvec™, une plateforme unifiée de vecteurs viraux à haut rendement destinée à accélérer le développement des thérapies géniques, de la fabrication au patient
23/06/2026
RANCHO CORDOVA, Californie, 23 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour le lancement de SKyvec™, sa plateforme exclusive et multimodale de vecteurs viraux. Conçue pour soutenir les programmes de [...]
Berry Street and Tia Partner to Deliver Clinical Nutrition Therapy at Every Stage of a Woman's Life
23/06/2026
Tia members gain access to Berry Street's AI-powered platform and network of 1,800+ Registered Dietitians specializing in women's health NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Berry Street , the leading metabolic [...]
X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson's Disease Therapy
23/06/2026
GAINESVILLE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- X-tosis Receives Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Novel Parkinson's Disease Therapy. The ward supports advancement of X- [...]
Peptide Mind Launches Expanded Research Library and Educational Tools for Peptide Research Community
23/06/2026
New platform resources provide structured, citation-backed peptide education and research tools for students, researchers, and science-minded readers. Official logo of the Peptide Mind research and education platform. [...]
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
23/06/2026
Engineered from the genomes of multiple butterfly species, Chrysalis transposase achieves fast cell recovery, stable expression over 60 cellular generations, and high expression across transgenes. In recent customer [...]
Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities
23/06/2026
The First Agentic Operating System for Life Sciences R&D PRESS RELEASE Already running NVIDIA BioNeMo in production, the SigmaticOS now leverages NVIDIA’s latest agentic innovations to connect AI agents, scientific [...]
EssilorLuxottica and Meta expand the accessibility of wearables category with new collection
23/06/2026
EssilorLuxottica and Meta expand the accessibility of wearables category with new collection Building on their market-leading portfolio of AI glasses, the two companies aim to introduce more consumers to smart eyewear [...]
EssilorLuxottica et Meta étendent l’accès à la catégorie des wearables avec une nouvelle collection
23/06/2026
EssilorLuxottica et Meta étendent l’accès à la catégorie des wearables avec une nouvelle collection Fortes d’un portefeuille de lunettes IA faisant référence, les deux entreprises visent à apporter l'innovation des [...]
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
23/06/2026
Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin’s recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto [...]
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
23/06/2026
Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic [...]
Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome
23/06/2026
QRX003 Holds Orphan Drug Designation in the United States, the European Union, and Japan, Plus Fast Track and Rare Pediatric Disease Designations from the FDA Pivotal Phase 3 Study Expected to Initiate in the Second [...]
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
23/06/2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
23/06/2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the [...]
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
23/06/2026
Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S. The Company now has multiple accounts and hospitals that have adopted the LIBERTY System across [...]
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences
23/06/2026
NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”) today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company [...]
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
23/06/2026
Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 ( [...]
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
23/06/2026
- First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world’s premier academic [...]
TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
23/06/2026
Growing demand reflects increasing investment in scalable decontamination technologies across healthcare, emergency response, and critical infrastructure sectors FREDERICK, Md., June 23, 2026 (GLOBE NEWSWIRE) -- TOMI [...]

Pages